Skip to Main Content

Author Details

Rong Li
University of Texas Health
1989
91
35
PMIDPaper TitleJournal TitlePublished Year
35247877Tumor Intrinsic PD-L1 Promotes DNA Repair in Distinct Cancers and Suppresses PARP Inhibitor-Induced Synthetic Lethality.Cancer Res2022
32770459Discovery of new small-molecule cyclin-dependent kinase 6 inhibitors through computational approaches.Mol Divers2021
33626233Bladder cancer cell-intrinsic PD-L1 signals promote mTOR and autophagy activation that can be inhibited to improve cytotoxic chemotherapy.Cancer Med2021
33898441A Phosphotyrosine Switch in Estrogen Receptor β Is Required for Mouse Ovarian Function.Front Cell Dev Biol2021
34421362BRCA1 Antibodies Matter.Int J Biol Sci2021
33462142Estrogen receptor beta signaling in CD8<sup>+</sup> T cells boosts T cell receptor activation and antitumor immunity through a phosphotyrosine switch.J Immunother Cancer2021
32226299PPARγ inhibition boosts efficacy of PD-L1 Checkpoint Blockade Immunotherapy against Murine Melanoma in a sexually dimorphic manner.Int J Biol Sci2020
32688199Structure-activity relationships of Wee1 inhibitors: A review.Eur J Med Chem2020
32956836The 3D genomic landscape of differential response to EGFR/HER2 inhibition in endocrine-resistant breast cancer cells.Biochim Biophys Acta Gene Regul Mech2020
32817394Genetic ablation of adipocyte PD-L1 reduces tumor growth but accentuates obesity-associated inflammation.J Immunother Cancer2020
30995943BRCA1 mutations attenuate super-enhancer function and chromatin looping in haploinsufficient human breast epithelial cells.Breast Cancer Res2019
30982901BRCA1-associated R-loop affects transcription and differentiation in breast luminal epithelial cells.Nucleic Acids Res2019
29212856Tamoxifen Resistance in Breast Cancer Is Regulated by the EZH2-ERα-GREB1 Transcriptional Axis.Cancer Res2018
30036938BRCA1 Interacting Protein COBRA1 Facilitates Adaptation to Castrate-Resistant Growth Conditions.Int J Mol Sci2018
30393583Adipose PD-L1 Modulates PD-1/PD-L1 Checkpoint Blockade Immunotherapy Efficacy in Breast Cancer.Oncoimmunology2018
29426838Gene-Specific Genetic Complementation between Brca1 and Cobra1 During Mouse Mammary Gland Development.Sci Rep2018
29326088Age effects of distinct immune checkpoint blockade treatments in a mouse melanoma model.Exp Gerontol2018
29298894Tumor-extrinsic discoidin domain receptor 1 promotes mammary tumor growth by regulating adipose stromal interleukin 6 production in mice.J Biol Chem2018
28654894Therapeutic utility of natural estrogen receptor beta agonists on ovarian cancer.Oncotarget2017
28649985Attenuation of RNA polymerase II pausing mitigates BRCA1-associated R-loop accumulation and tumorigenesis.Nat Commun2017
26941120Genetic suppression reveals DNA repair-independent antagonism between BRCA1 and COBRA1 in mammary gland development.Nat Commun2016
28798885Tumor cell-intrinsic PD-L1 promotes tumor-initiating cell generation and functions in melanoma and ovarian cancer.Signal Transduct Target Ther2016
27671674Tumor-Intrinsic PD-L1 Signals Regulate Cell Growth, Pathogenesis, and Autophagy in Ovarian Cancer and Melanoma.Cancer Res2016
27323858Tyrosine phosphorylation regulates ERβ ubiquitination, protein turnover, and inhibition of breast cancer.Oncotarget2016
25659039Damage-induced BRCA1 phosphorylation by Chk2 contributes to the timing of end resection.Cell Cycle2015
26052229Effects of Radiation Therapy on Breast Epithelial Cells in BRCA1/2 Mutation Carriers.Breast Cancer (Auckl)2015
25853030Effects of six months of Yoga on inflammatory serum markers prognostic of recurrence risk in breast cancer survivors.Springerplus2015
26010750Translational Initiation at a Non-AUG Start Codon for Human and Mouse Negative Elongation Factor-B.PLoS One2015
24249424Motivation, exercise, and stress in breast cancer survivors.Support Care Cancer2014
25234841Genome-wide DNA methylation profiling reveals parity-associated hypermethylation of FOXA1.Breast Cancer Res Treat2014
24960160A phosphotyrosine switch determines the antitumor activity of ERβ.J Clin Invest2014
24656816Negative elongation factor controls energy homeostasis in cardiomyocytes.Cell Rep2014
24458825Association of obesity and circulating adipose stromal cells among breast cancer survivors.Mol Biol Rep2014
23652009Regulation of adipose oestrogen output by mechanical stress.Nat Commun2013
24097989A conserved protein motif is required for full modulatory activity of negative elongation factor subunits NELF-A and NELF-B in modifying glucocorticoid receptor-regulated gene induction properties.J Biol Chem2013
23948299Amplification of distant estrogen response elements deregulates target genes associated with tamoxifen resistance in breast cancer.Cancer Cell2013
23210696Association of radiotherapy with preferential depletion of luminal epithelial cells in a BRCA1 mutation carrier.Exp Hematol Oncol2012
20526739Aromatase immunoreactivity is increased in mammographically dense regions of the breast.Breast Cancer Res Treat2011
21865163Genetic and genomic analyses of RNA polymerase II-pausing factor in regulation of mammalian transcription and cell growth.J Biol Chem2011
21377485Mechanical phenotype is important for stromal aromatase expression.Steroids2011
19969081Cell density is a critical determinant of aromatase expression in adipose stromal cells.J Steroid Biochem Mol Biol2010
20420826Cell density-dependent transcriptional activation of endocrine-related genes in human adipose tissue-derived stem cells.Exp Cell Res2010
20028984Human negative elongation factor activates transcription and regulates alternative transcription initiation.J Biol Chem2010
18997820Decreased BRCA1 confers tamoxifen resistance in breast cancer cells by altering estrogen receptor-coregulator interactions.Oncogene2009
19340312Mouse cofactor of BRCA1 (Cobra1) is required for early embryogenesis.PLoS One2009
19483720Interleukin 6 secreted from adipose stromal cells promotes migration and invasion of breast cancer cells.Oncogene2009
19221050IKKbeta mediates cell shape-induced aromatase expression and estrogen biosynthesis in adipose stromal cells.Mol Endocrinol2009
19282383The alternative noncoding exons 1 of aromatase (Cyp19) gene modulate gene expression in a posttranscriptional manner.Endocrinology2009
17910036Deregulation of cofactor of BRCA1 expression in breast cancer cells.J Cell Biochem2008
18259752BRCA1 transcriptional activity is enhanced by interactions between its AD1 domain and AhR.Cancer Chemother Pharmacol2008
  • 1 - 50 of 91

Recommended Authors

Rahul K Kollipara
McDermott Center for Human Growth and Development.
Career Start Year 2010
Number of shared co-authors 0
Richard Mitter
The Francis Crick Institute
Career Start Year 2008
Number of shared co-authors 0
Yue Lu
The University of Texas MD Anderson Cancer Center
Career Start Year 2006
Number of shared co-authors 0
Anna V??h??rautio
University of Helsinki
Career Start Year 2006
Number of shared co-authors 0
Wilbert Zwart
Oncode Institute, The Netherlands Cancer Institute
Career Start Year 2004
Number of shared co-authors 1
Silvano Piazza
International Centre for Genetic Engineering and Biotechnology
Career Start Year 2004
Number of shared co-authors 0
Jason Gertz
Huntsman Cancer Institute, University of Utah
Career Start Year 2003
Number of shared co-authors 1
Genevi??ve Deblois
Institute for Research in Immunology and Cancer (IRIC), University of Montreal
Career Start Year 2003
Number of shared co-authors 0
Anupama E Gururaj
National Institute of Allergy and Infectious Disease, National Institutes of Health
Career Start Year 2002
Number of shared co-authors 0
Yuelin J Zhu
National Cancer Institute, National Institutes of Health
Career Start Year 2002
Number of shared co-authors 3
Juliet D French
QIMR Berghofer Medical Research Institute
Career Start Year 2001
Number of shared co-authors 1
Jennifer Cruickshank
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2000
Number of shared co-authors 0
Stacey L Edwards
QIMR Berghofer Medical Research Institute
Career Start Year 1999
Number of shared co-authors 1
Marcelo A Carvalho
Instituto Nacional de Cancer, Programa de Pesquisa Clinica
Career Start Year 1999
Number of shared co-authors 0
Jianjun Shen
The University of Texas MD Anderson Cancer Center
Career Start Year 1998
Number of shared co-authors 0
Cecilia Williams
Karolinska Institutet
Career Start Year 1997
Number of shared co-authors 0
Shiaw-Yih Lin
The University of Texas MD Anderson Cancer Center
Career Start Year 1996
Number of shared co-authors 0
Peter D Adams
Sanford Burnham Prebys Medical Discovery Institute
Career Start Year 1991
Number of shared co-authors 2
Brian D Dynlacht
New York University Cancer Institute, New York University School of Medicine
Career Start Year 1989
Number of shared co-authors 0
Eldad Zacksenhaus
University of Toronto
Career Start Year 1988
Number of shared co-authors 0
Josephine C Dorsman
Cancer Center Amsterdam
Career Start Year 1988
Number of shared co-authors 0
Rakesh Kumar
Rutgers New Jersey Medical School
Career Start Year 1987
Number of shared co-authors 1
Alvaro N A Monteiro
H. Lee Moffitt Cancer Center & Research Institute
Career Start Year 1985
Number of shared co-authors 1
Andrew D Cherniack
Dana-Farber Cancer Institute
Career Start Year 1984
Number of shared co-authors 0
Ralf Kittler
McDermott Center for Human Growth and Development.
Career Start Year 1984
Number of shared co-authors 0
Ashok R Venkitaraman
University of Cambridge, Hutchison Research Centre
Career Start Year 1982
Number of shared co-authors 0
Alan Ashworth
UCSF Helen Diller Family Comprehensive Cancer Center
Career Start Year 1982
Number of shared co-authors 2
Stephen J Elledge
Howard Hughes Medical Institute, Brigham and Women's Hospital, Harvard Medical School
Career Start Year 1982
Number of shared co-authors 1
Edison T Liu
USA The Jackson Laboratory Cancer Center
Career Start Year 1982
Number of shared co-authors 0
Peggy J Farnham
Keck School of Medicine of USC
Career Start Year 1978
Number of shared co-authors 1

Collaborators

Michael R Botchan
University of California berkeley
Co-authored papers 10
Tsuyoshi Miyake
University of Virginia School of Medicine
Co-authored papers 6
Jian-Bing Fan
Nanfang Hospital and Basic Medical College, Southern Medical University
Co-authored papers 5
Tim H-M Huang
University of Texas Health San Antonio (UTHSA)
Co-authored papers 5
Christian M Loch
Fred Hutchinson Cancer Research Center
Co-authored papers 3
Yidong Chen
The University of Texas Health Science Center at San Antonio
Co-authored papers 2
Kevin G Hardwick
Institute of Cell Biology, University of Edinburgh
Co-authored papers 1
Ben Ho Park
Vanderbilt University Medical Center
Co-authored papers 1
Aaron M Horning
Co-authored papers 1
Stefan Bekiranov
University of Virginia
Co-authored papers 1
Shelley L Berger
Penn Epigenetics Institute, Perelman School of Medicine
Co-authored papers 1
Joel E Michalek
University of Texas Health Science Center
Co-authored papers 1
Susan T Weintraub
University of Texas Health Science Center at San Antonio Texas78229 USA.
Co-authored papers 1
Oscar M Rueda
University of Cambridge
Co-authored papers 1
Myles Brown
Co-authored papers 1
Justin T Reese
Lawrence Berkeley National Laboratory
Co-authored papers 1
Tanya T Paull
University of Texas at Austin
Co-authored papers 1
Gregory J Aune
Co-authored papers 1
Paul D Robbins
University of Minnesota
Co-authored papers 1
Claudine Isaacs
Co-authored papers 1
David T Auble
University of Virginia
Co-authored papers 1
Hiroshi Handa
Center for Future Medical Research, Tokyo Medical University
Co-authored papers 1
Andrew S Belmont
Co-authored papers 1
Carson C Chow
National Institute of Diabetes and Digestive and Kidney Diseases
Co-authored papers 1
Kathleen R Brandt
Mayo Clinic
Co-authored papers 1
Zhao Zhang
Co-authored papers 1
James N Ingle
Mayo Clinic
Co-authored papers 1
Lang Li
Harbin Medical University
Co-authored papers 1
Richard J Santen
Co-authored papers 1
Christopher G Scott
Mayo Clinic
Co-authored papers 1
Release 1.2